CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
Clinical trial NCT05215470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05215470
- Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2024-11-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.